Episode 3: Young Adult AML: Understanding the Gaps & Closing Them
SpotifyOverview
This episode explores the unique challenges faced by adolescents and young adults (AYAs) with acute myeloid leukemia (AML), focusing on survival disparities, the impact of race, financial and logistical barriers to treatment, and the importance of patient stories. Dr. Erin Feliciano discusses her research on survival disparities among AYA AML patients, highlighting the need for more inclusive research and better access to clinical trials. The conversation emphasizes the importance of understanding the holistic experiences of patients and the need for systemic changes in healthcare to address these disparities.
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. Erin Feliciano
Dr. Feliciano is an AML researcher focused on the AYA population out of Mount Sinai Hospital in New York City
Transcript
